Minimizing Contamination During Biopharma R&D
The right approach to biological safety cabinets, and collaboration between engineers and those who will operate the equipment, is crucial to preventing cell-culture contamination.
The right approach to biological safety cabinets (BSC), and collaboration between engineers and those who will operate the equipment, is crucial to preventing cell-culture contamination. This article summarizes the key criteria for assessing BSC performance so that it prevents contamination.
Read this article in Pharmaceutical Technology's Biologics and Sterile Drug Manufacturing eBook.
Article Details
Pharmaceutical Technology
eBook: Biologics and Sterile Drug Manufacturing
May 2020
Pages: 34–37
Citation
When referring to this article, please cite it as D. Phillips, "Minimizing Contamination During Biopharma R&D," Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2020).
FDA Approves Novartis Oral Treatment for Adults with C3 Glomerulopathy
March 25th 2025Fabhalta (iptacopan) received a positive opinion for treatment of C3G from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) and has been approved twice before by FDA.
Benuvia Granted GMP Certification by Brazil National Health Surveillance Agency
March 14th 2025The certification allows Benuvia to produce pharmaceutical products for companies, either local to Brazil or international, that may be looking for compliant and high-quality production capabilities in the Brazilian pharmaceutical market.
